The Correlation of Serum Adropin with Cardiovascular Risk Factors in the Experimental Rat Model of Chronic Kidney Disease and Its Implication in the Ameliorative Effect of Angiotensin-Converting Enzyme Inhibitors.
Adropin levels were significantly correlated with most CVD risk factors in CKD and captopril-treated CKD rats, indicating a role for adropin in the pathogenesis of CVD in CKD. It also refers to its implication in the ameliorative effect of ACEI treatment, possibly by affecting VEGFR-2 and nitric oxide release.
Authors
- Enas N. Morgan (ORCID: https://orcid.org/0000-0001-5427-7126)
- Enssaf Ahmad Ahmad (ORCID: https://orcid.org/0000-0003-0660-1942)
- Mai Ahmed Gobran (ORCID: https://orcid.org/0000-0002-1395-372X)
- Ashwag Saleh Alsharidah (ORCID: https://orcid.org/0000-0003-0923-7525)
- Sulaiman Mohammed Alnasser (ORCID: https://orcid.org/0000-0001-8678-5029)
- Samaa AbdEl-Fatah
- Raja Aljafil
- Salim Awadh
- Mohammed Alorini (ORCID: https://orcid.org/0000-0003-2452-1321)
- Mohamed Ali Alabiad (ORCID: https://orcid.org/0000-0002-8415-4474)
- Maha Fathy
Institutions
- Qassim University (SA)
- Zagazig University (EG)
- University of Benghazi (LY)
Publication Details
- Journal
- PubMed
- Published
- 2024-12-01
- DOI
- https://doi.org/10.30476/ijms.2024.99442.3152
- Primary Topic
- Adipose Tissue and Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Zagazig University